FDA Inspection 1227090 — Kang-Yun Lee, MD, PhD
The FDA completed an inspection of Kang-Yun Lee, MD, PhD on Dec 8, 2023 in Jhonghe City. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Jhonghe City (Taiwan)
Additional Details
Clinical Investigator (CI)